Journal Detail

Journal Name
ISSN (P) 3105-6628
ISSN (O) 3105-6636
Country Macao
Frequency Bi-Monthly
Journal Discipline
Area of specialization
Organization
Journal Language
Year of First Publication 2025
Web Site myzlx.scionline2025.com
Editor Yuchen Guo
Indexed
Email questpress@hotmail.com
Phone No. +853 6881 9699
Cosmos Impact Factor
Journal Description

Chinese Journal Title: Mian Yi Zhong Liu Xue (Immuno-Oncology) English Journal Title: Immuno-Oncology International Standard Serial Number (ISSN): ISSN 3105-6628 (Print) ISSN 3105-6636 (Online) CODEN: MZABB7 Identifier Assigning Agencies: Chemical Abstracts Service (CAS) China International Book Trading Corporation (CIBTC) Import Registration Number: G015Z129 Publication Model: Gold Open Access (Gold OA) Full texts are permanently freely accessible under the CC BY 4.0 license. Publisher: Macau Sino-Foreign Medical Publishing Limited Publication Frequency: Bimonthly Publication Languages: Chinese, English Submission Requirements: Submissions in Chinese are accepted (must be accompanied by an English title, abstract, keywords, author affiliations, and author names). Core Positioning Immuno-Oncology is an authoritative academic journal focusing on cutting-edge basic research in tumor immunology and its translation into clinical innovation. The journal is dedicated to systematically advancing theoretical breakthroughs and technological innovations in the field of tumor immunotherapy, with a particular emphasis on core scientific issues such as immune checkpoint regulatory mechanisms, dynamic remodeling of the tumor microenvironment, innovative cell therapy technologies, and the development of precision biomarkers. We strongly advocate for interdisciplinary research paradigms that integrate advanced methodologies from immunology, tumor biology, molecular medicine, and computational biology, aiming to provide solid theoretical foundations and innovative solutions for the clinical practice of tumor immunotherapy.